Document Server@UHasselt >
Research >
Research publications >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/15103

Title: Non-Hodgkin Lymphoma after treatment with Extended dosing temozolomide and radiotherapy for a glioblastoma: A case report
Authors: Van Ginderachter, Laura
Cox, Tony
Drijkoningen, Ria
Achten, Ruth
Joosens, Eric
Maes, Annelies
Theunissen, Koen
Mebis, Jeroen
Issue Date: 2013
Citation: Case Report Oncology, 6, p. 45-49
Abstract: Temozolomide (TMZ) is an alkylating agent, used for the treatment of high-grade gliomas. This case report describes the development of a non-Hodgkin lymphoma in a patient treated with extended-dose temozolomide and radiotherapy. In addition to the possible mutagenic effect of temozolomide – as described for all alkylating agents – there might have been an immunosuppressive effect of TMZ. The pathological appearance of the lymphoma as well as the presence of a grade 3 lymphopenia early in treatment supports this hypothesis. As the use of TMZ increases, the awareness that TMZ may induce secondary malignancies should increase as well.
URI: http://hdl.handle.net/1942/15103
DOI: 10.1159/000346614
ISSN: 1662-6575
Category: A2
Type: Journal Contribution
Appears in Collections: Research publications

Files in This Item:

There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.